ABVC BioPharma, Inc. Common Stock

ABVCNASDAQ • USD
ThemeBiotech - Drug Development›Clinical-Stage Platforms
1.05 USD
↗ 0.01 (0.96%)AT CLOSE (03:59 PM EDT)
1.06
↗ 0.01 (0.48%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
1.06
↗ 0.01 (0.48%)
🔴Market: CLOSED

ABVC BioPharma, Inc. Common Stock (ABVC) trades at $1.06 per share. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, ABVC trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Oct 26, 2026.

Open?$1.04
High?$1.07
Low?$1.03
Prev. Close?$1.04
Volume?36.6K
Avg. Volume?98.6K
VWAP?$1.06
Rel. Volume?0.37x
Bid / Ask
Bid?$1.06 × 200
Ask?$1.07 × 200
Spread?$0.01
Midpoint?$1.07
Valuation & Ratios
Market Cap?28.0M
Shares Out?26.7M
Float?21.6M
Float %?81.0%
P/E Ratio?N/A
P/B Ratio?2.72
EPS?-$0.13
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
Themes
Biotech - Drug Development›Clinical-Stage Platforms
Employees
19
Market Cap
27.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.abvcpharma.com
Listed
2004-11-09
Address
44370 OLD WARM SPRINGS BLVD.
FREMONT, CA 94538
Phone: 510-668-0881
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
61
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.26Distress
Confidence?49%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?2.73%Low
Short Interest?589.9K
Days to Cover?6.9
Free Float21.6M
Avg Daily Volume85.2K
Settlement Date2026-10-15
Financial Health
Current Ratio?0.07Weak
Quick Ratio?0.07Weak
Cash Ratio?0.01Low
Debt/Equity?0.01Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
60
2.72CHEAP▾
P/S?
Peers
100
S&P
3
35.21HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-8.0CHEAP▾
EV/Sales?
Peers
100
S&P
3
35.25HIGH▾
Returns & Efficiency
ROE?
S&P
5
-34.4%WEAK▾
ROA?
S&P
3
-18.3%WEAK▾
Cash Flow & Enterprise
FCF?$-2696742
Enterprise Value?$28.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist